- Home
- HRZN vs CATX Comparison
HRZN vs CATX Comparison
Compare HRZN & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRZN
- CATX
- Stock Information
- Founded
- HRZN 2008
- CATX 1983
- Country
- HRZN United States
- CATX United States
- Employees
- HRZN N/A
- CATX N/A
- Industry
- HRZN Finance/Investors Services
- CATX Medical/Dental Instruments
- Sector
- HRZN Finance
- CATX Health Care
- Exchange
- HRZN Nasdaq
- CATX Nasdaq
- Market Cap
- HRZN 295.3M
- CATX 239.0M
- IPO Year
- HRZN 2010
- CATX N/A
- Fundamental
- Price
- HRZN $6.89
- CATX $3.62
- Analyst Decision
- HRZN Hold
- CATX Strong Buy
- Analyst Count
- HRZN 4
- CATX 11
- Target Price
- HRZN $7.81
- CATX $12.90
- AVG Volume (30 Days)
- HRZN 672.5K
- CATX 649.3K
- Earning Date
- HRZN 08-07-2025
- CATX 08-13-2025
- Dividend Yield
- HRZN 19.14%
- CATX N/A
- EPS Growth
- HRZN N/A
- CATX N/A
- EPS
- HRZN N/A
- CATX N/A
- Revenue
- HRZN $97,144,000.00
- CATX $1,235,000.00
- Revenue This Year
- HRZN $0.51
- CATX N/A
- Revenue Next Year
- HRZN $9.90
- CATX N/A
- P/E Ratio
- HRZN N/A
- CATX N/A
- Revenue Growth
- HRZN N/A
- CATX N/A
- 52 Week Low
- HRZN $6.77
- CATX $1.60
- 52 Week High
- HRZN $11.15
- CATX $16.31
- Technical
- Relative Strength Index (RSI)
- HRZN 29.37
- CATX 47.63
- Support Level
- HRZN $6.86
- CATX $3.42
- Resistance Level
- HRZN $6.96
- CATX $3.68
- Average True Range (ATR)
- HRZN 0.10
- CATX 0.24
- MACD
- HRZN -0.01
- CATX -0.01
- Stochastic Oscillator
- HRZN 6.88
- CATX 41.88
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.